A Randomized, Open-Labeled, Multi-Center Study to Investigate the Safety and Efficacy of OROS Hydromorphone HCl Comparing With Morphine SR in Cancer Pain Patients

Trial Profile

A Randomized, Open-Labeled, Multi-Center Study to Investigate the Safety and Efficacy of OROS Hydromorphone HCl Comparing With Morphine SR in Cancer Pain Patients

Discontinued
Phase of Trial: Phase III

Latest Information Update: 09 Aug 2013

At a glance

  • Drugs Hydromorphone; Morphine
  • Indications Cancer pain
  • Focus Therapeutic Use
  • Sponsors Johnson & Johnson
  • Most Recent Events

    • 09 Aug 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 09 Jan 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Jan 2010 Actual initiation date (Aug 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top